UPDATE : Tuesday, September 26, 2017
Ministry changes dosage recommendation for Bayer’s blood-thinning drug by Marian Chu 2017-09-26 16:24
Pfizer launches ‘V-Rep’ for doctors helping smokers quit by Marian Chu 2017-09-26 13:30
Sanofi Genzyme to launch metastatic colorectal cancer drug in Korea by Marian Chu 2017-09-26 11:07
‘We’re starting long journey toward complete cure of cancer’ by Marian Chu 2017-09-26 09:25
Cancer remains leading cause of death in Korea by Marian Chu 2017-09-22 18:03
KCDC sets interim guidelines for polio vaccine shortage by Marian Chu 2017-09-21 18:18
Biosimilar prescriptions fall by the wayside in Korea by Marian Chu 2017-09-21 14:56
MSD dissolves promotion team for Samsung Bioepis’ biosimilars by Lee Han-soo 2017-09-21 11:58
AIA Korea kicks off health and wellness summit with David Beckham by Marian Chu 2017-09-20 17:04
3 Korean start-ups complete Bayer-KOTRA accelerator program by Marian Chu 2017-09-20 15:34
FDA panel split evenly over Pfizer’s kidney cancer drug by Marian Chu 2017-09-20 12:27
Novo Nordisk Korea walks fine line marketing obesity drug by Marian Chu 2017-09-20 06:00
Korean biopharmaceutical industry ranked 2nd among emerging countries by Marian Chu 2017-09-19 10:37
Global alliance project with Novo Nordisk opens in Korea by Marian Chu 2017-09-18 17:14
Opdivo adds one more melanoma indication by Marian Chu 2017-09-18 11:34
In historic move, FDA approves 1st biosimilar to treat cancer by Marian Chu 2017-09-15 11:40
NOAC race: Pradaxa prescription numbers fall behind fast followers by Marian Chu 2017-09-14 19:02
Opdivo vs. Keytruda - which will doctors choose? by Marian Chu 2017-09-14 17:54
AstraZeneca regains momentum with positive Imfinzi results by Marian Chu 2017-09-14 13:34
Amgen, Chong Kun Dang to sell osteoporosis drug in Korea by Marian Chu 2017-09-13 18:33
Back to Top